Encouraging prospects with sugemalimab in relapsed or refractory extranodal natural killer/T-cell lymphoma
Year: 2023
Type: article
Source: Chinese Clinical Oncology
DOI: 10.21037/cco-23-69
Institutions: Duke University, Duke Medical Center
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4389567547
